53m
Is Ionis’ Raised Revenue Outlook and Positive Phase 3 Data Shifting the Investment Case for IONS?
Ionis Pharmaceuticals reported third quarter revenue of US$157 million and reduced its net loss to US$129 million, while also raising its full-year 2025 revenue guidance to a range of US$875 million ...
Now in its inaugural year, AI FilmFest Japan showcases the world's leading experiments in AI-assisted cinema, bringing ...
Microsoft has added powerful no-code tools to Copilot, enabling Microsoft 365 users to build apps, automate workflows, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback